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Olfactory neuroblastoma, also known as esthesioneuroblastoma, is a rare malignant head and neck
tumor. Olfactory neuroblastoma accounts for approximately 3e5% of all malignant nasal tumors. We
present a case of olfactory neuroblastoma in a 61-year-old man who underwent endoscopic surgery
followed by postoperative irradiation. Right neck metastasis was diagnosed about 6 months after
endoscopic surgery. Supraomohyoid dissection of the right side of the neck was performed, but right
parotid metastasis was identiﬁed about 3 months later. Boost radiotherapy was applied to the right
metastatic parotid. There was no evidence of recurrence on head and neck magnetic resonance imaging
and endoscopic examination during the 2-year follow-up.
Copyright  2011, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
All rights reserved.1. Introduction
Olfactory neuroblastoma, also called esthesioneuroblastoma, is
a rare head and neck malignant tumor. Olfactory neuroblastoma
accounts for approximately 3e5% of all malignant nasal tumors
[1]. Here we describe a patient with olfactory neuroblastoma
who underwent endoscopic surgery followed by postoperative
irradiation.
2. Case report
A 61-year-old man had experienced occasional nasal obstruc-
tion and epistaxis when sneezing for 2 years. Anosmia was also
reported. Physical examination showed a bilateral nasal tumor that
bled easily (Figs. 1A and 1B). Computed tomography revealed an
inﬁltrative, enhancing mass lesion in the bilateral nasal meatuses
and ethmoid and sphenoid sinuses, with invasion and destruction
of the walls of the sinuses (Fig. 2A). The skull base was invaded by
the tumor through the left cribriform plate (Fig. 2B). No neck or
parotid metastasis was found (Figs. 2C and 2D).logy, Buddhist Dalin Tzu Chi
ayi, Taiwan. Tel.: þ886 5
iao).
ddhist Compassion Relief Tzu ChiWe performed a biopsy under local anesthesia. Histopatholog-
ical examination revealed clusters of inﬁltrating small round blue
cells with hyperchromatic nuclei, a scanty delicate cytoplasm, and
scattered mitoses (Fig. 3). The morphological picture was that of
olfactory neuroblastoma. An immunohistochemical study revealed
that most of the tumor cells reacted positively for the neuronal
markers cytokeratin, synaptophysin, and chromogranin-A. Because
the tumor had invaded the cribriform plate and skull base, it was
classiﬁed as Stage C according to the Kadish classiﬁcation (Table 1).
The tumor was located over the bilateral nasal cavity and through
the posterior portion of the nasal septum, and it bled easily on
touch. Preoperative evaluation, including an abdominal ultrasound
and whole-body bone scan, demonstrated no distant metastasis.
Piecemeal excision of the intranasal tumor was performed carefully
by a microdebrider. No serious complications, such as leakage of
cerebrospinal ﬂuid or intracranial hemorrhage, were observed in
this patient. The patient underwent postoperative tumor bed
radiotherapy of 6120 cGy for 7 weeks.
About 6 months after endoscopic surgery, a 3-cm 3-cm mass
was noted over the right neck Level II. Supraomohyoid neck
dissection of the right side was performed, and pathological
examination showed metastatic carcinoma similar to the previous
olfactory neuroblastoma. A postoperative examinationwith whole-
body 18F-ﬂuorodeoxy-glucose positron emission tomography
performed about 3 weeks after the procedure demonstrated noFoundation. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. (A) A nasal tumor that bleeds easily is observed on endoscopy of the right nasal cavity. (B) A nasal tumor is seen over the left nasal cavity through the posterior portion of the
nasal septum.
Fig. 2. (A) Axial CT shows an inﬁltrative, enhancing mass lesion in the bilateral nasal meatuses with invasion and destruction of the sinus walls. (B) Coronal CT shows that the skull
base has been invaded by the tumor. (C and D) No neck or parotid metastasis is seen. CT¼computed tomography.
Fig. 3. (A) Microscopic view shows clusters of inﬁltrating small round blue cells with hyperchromatic nuclei, a scanty delicate cytoplasm, and scattered mitoses (H and E, original
magniﬁcation: 200) (B) Many rosette-like structures are seen (H and E, original magniﬁcation: 400). H and E¼ hematoxylin-eosin stain.
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Table 1
Kadish olfactory neuroblastoma staging.
Stage Deﬁnition
A Tumor limited to nasal cavity
B Tumor conﬁned to nasal and paranasal sinuses
C Tumor extending to cribriform plate, base of skull, orbit, or intracranial
cavity
Table 2
Hyam’s histopathological grading system of olfactory neuroblastoma.
Grade Lobular
architecture
preservation
Mitotic
index
Nuclear
polymorphism
Fibrillary
matrix
Rosettes Necrosis
I þ None None Prominent HW rosettes None
II þ Low Moderate Present HW rosettes None
III þ/ Moderate Prominent Low FW rosettes Rare
IV þ/ High Marked Absent None Frequent
FW¼ Flexner-Wintersteiner; HW¼Homer-Wright.
Z.-S. Wu et al. / Tzu Chi Medical Journal 23 (2011) 131e134 133signiﬁcant 18F-ﬂuorodeoxy-glucose-avid hypermetabolic lesions in
the nasal cavity (Fig. 4). However, right parotid swelling and
tenderness were noted by the patient 5 weeks after the positron
emission tomography. A right parotid sonography revealed an
ovoid hypoechoic nodule about 1.5 cm 0.86 cm over the superﬁ-
cial lobe of the right parotid gland. A ﬁne-needle biopsy was per-
formed, and cytology revealed metastatic carcinoma. Because the
patient was scheduled to receive radiotherapy, a total dose of
7200 cGy radiation was boosted to the right metastatic parotid.
Head and neck magnetic resonance imaging and endoscopic
examination showed no evidence of recurrence during the 2-year
follow-up.
3. Discussion
Olfactory neuroblastoma is a locally extensive malignancy that
frequently invades the skull base, orbits, and adjacent vital organs.
Up to 70% of the patients were in advanced tumor stages at the time
of initial diagnosis [2]. In Hyam’s classiﬁcation (Table 2), tumors are
graded 1 through 4, with those showing less differentiation
receiving higher grades [3]. The Kadish system is based on the
spread of the tumor [4]. In this system, Stage A tumors are conﬁned
to the nasal cavity; Stage B tumors involve the paranasal sinuses;
and Stage C lesions extend over the paranasal sinuses, including theFig. 4. Postoperative positron emission tomography scan performed about 3 weeks after th
neck.cribriform plate, base of the skull, orbit, or intracranial cavity. This
patient had a Grade 3 Stage C lesion that had invaded the cribriform
plate and skull base.
Surgery is the mainstream treatment for olfactory neuroblas-
toma. Traditionally, cranial facial resection entails serious compli-
cations, morbidity, and long hospitalizations [5]. Themost common
complications include leakage of cerebrospinal ﬂuid, intracranial
hemorrhage, and infection. In recent years, many surgeons and
oncologists have begun treating olfactory neuroblastoma with
a minimally invasive approach with good results [6e8]. Our patient
was treated with combined intranasal endoscopic resection and
radiotherapy. No other major complications were observed despite
the relatively high incidence of complications in craniofacial series.
Distant and regional metastases are present in 14e38% of
patients with olfactory neuroblastoma; the cervical lymph nodes,
lung, and bone are the most commonly involved sites [9]. Our
patient had right neck metastasis 6 months after the operation. The
issue of elective treatment of the cervical lymph nodes in olfactory
neuroblastoma is controversial. It is not clear whether prophylactic
neck irradiation alters the natural history of the disease or adds
a survival beneﬁt [10].e right neck dissection demonstrates no signiﬁcant lesion in the bilateral parotids or
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arising from the olfactory epithelium and is characterized by
frequent local or regional recurrence. Combined intranasal endo-
scopic resection and radiotherapy minimizes injury to the patient.
However, a longer follow-up is needed to determine the oncolog-
ical outcome for this patient.References
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